INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 43h ago
House PTR3h ago
SEC 13F3h ago
Robinhood Chain3h ago

Most active filers · 30d

  1. 01Kurtz George0B / 217S · 10 late217 trades$54.77M
  2. 02SPSaba Capital Management, L.P.55B / 19S · 3 late74 trades$23.87M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04CFCheng Chi Fung0B / 42S42 trades$15.33M
  5. 05RARothblatt Martine A0B / 33S33 trades$5.50M
  6. 06RJRubinstein Julie0B / 32S32 trades$5.55M
  7. 07LBLeach Bryan0B / 30S30 trades$7.97M
  8. 08AOAtay Oguzhan0B / 30S30 trades$7.55M
  9. 09JDJenkins William D Jr0B / 30S30 trades$13.38M
  10. 10BSBiswas Sanjit0B / 28S28 trades$22.33M

Cluster activity · 60d

  1. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  2. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  3. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  4. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  5. SELLIBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
  6. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
  7. BUYBBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K
  8. SELLBCYCBICYCLE THERAPEUTICS PLCOct 2 – Oct 56 insiders$63K

Form 4 transactions

21,251 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
14
MJ
Mohan JitendraDirector, Chief Executive Officer
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$662K
2,841 sh
May 18, 2026
Page 267 of 532
← PrevNext →
May 20, 2026
traded May 18, 2026
+2d
SEC Form 4

Evidence

14
SA
Sander Dale A.CFO and Chief Corp. Dev. Off
HUMAHumacyte, Inc.
Open-market sale · 10b5-1 plan
SELL$41K
45.9K sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

14
MJ
Mohan JitendraDirector, Chief Executive Officer
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$426K
1,848 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

14
MA
Maheshwari AnshulChief Financial Officer
SIBNSI-BONE, Inc.
Open-market sale
SELL$36K
2,477 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

14
MJ
Mohan JitendraDirector, Chief Executive Officer
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$710K
3,247 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

14
MJ
Mohan JitendraDirector, Chief Executive Officer
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$391K
1,782 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

14
MJ
Mohan JitendraDirector, Chief Executive Officer
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$520K
2,356 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

14
MJ
Mohan JitendraDirector, Chief Executive Officer
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$257K
1,158 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

14
MJ
Mohan JitendraDirector, Chief Executive Officer
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$530K
2,375 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

14
MJ
Mohan JitendraDirector, Chief Executive Officer
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$538K
2,320 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

14
MJ
Mohan JitendraDirector, Chief Executive Officer
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$280K
1,189 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

14
PJ
Parikh Shamik JChief Medical Officer
HUMAHumacyte, Inc.
Open-market sale · 10b5-1 plan
SELL$41K
45.9K sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

14
MA
Maheshwari AnshulChief Financial Officer
SIBNSI-BONE, Inc.
Open-market sale
SELL$32K
2,189 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

14
MJ
Mohan JitendraDirector, Chief Executive Officer
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$421K
1,996 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

13
MP
Menu PhilippeChief Medical Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$2,800
608 sh
May 19, 2026May 20, 2026
traded May 19, 2026
+1dSEC Form 4

Evidence

13
CJ
Camblong JurgiDirector, Chief Executive Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$21K
4,486 sh
May 19, 2026May 20, 2026
traded May 19, 2026
+1dSEC Form 4

Evidence

13
HT
Herb TylerChief Accounting Officer
FIGFigma, Inc.
Open-market sale · 10b5-1 plan
SELL$16K
669 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

13
MR
Muken RossPresident
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$3,501
761 sh
May 19, 2026May 20, 2026
traded May 19, 2026
+1dSEC Form 4

Evidence

13
XZ
Xu ZhenyuChief Scientific Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$2,798
608 sh
May 19, 2026May 20, 2026
traded May 19, 2026
+1dSEC Form 4

Evidence

13
VD
Van Well DaanChief Legal Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$3,149
684 sh
May 19, 2026May 20, 2026
traded May 19, 2026
+1dSEC Form 4

Evidence

11
RN
Reskos NikolaosChief Operating Officer
SBLKStar Bulk Carriers Corp.
Open-market sale · 10b5-1 plan
SELL$870K
33.1K sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

11
HT
Holme TimothyCHIEF TECHNOLOGY OFFICER
QSQuantumScape Corp
Open-market sale · 10b5-1 plan
SELL$1.13M
150.2K sh
May 20, 2026May 20, 2026
traded May 20, 2026
+0dSEC Form 4

Evidence

11
MJ
Mohan JitendraDirector, Chief Executive Officer
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$200K
800 sh
May 19, 2026May 20, 2026
traded May 19, 2026
+1dSEC Form 4

Evidence

11
MJ
Mohan JitendraDirector, Chief Executive Officer
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$249K
1,100 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

11
MJ
Mohan JitendraDirector, Chief Executive Officer
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$95K
423 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

10
KS
Kereere SuzanPresident, Global Markets
PYPLPayPal Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$8,973
200 sh
May 19, 2026May 20, 2026
traded May 19, 2026
+1dSEC Form 4

Evidence

9
GV
Gupta VikramSee Remarks
SYNASYNAPTICS Inc
Open-market sale · 10b5-1 plan
SELL$79K
692 sh
May 19, 2026May 20, 2026
traded May 19, 2026
+1dSEC Form 4

Evidence

3
BM
Brosius MarkEVP & Chief Mfg and Supply Cha
ISRGINTUITIVE SURGICAL INC
Open-market sale · 10b5-1 plan
SELL$7,604
18 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

3
BM
Brosius MarkEVP & Chief Mfg and Supply Cha
ISRGINTUITIVE SURGICAL INC
Open-market sale · 10b5-1 plan
SELL$7,933
18 sh
May 19, 2026May 20, 2026
traded May 19, 2026
+1dSEC Form 4

Evidence

3
BM
Brosius MarkEVP & Chief Mfg and Supply Cha
ISRGINTUITIVE SURGICAL INC
Open-market sale · 10b5-1 plan
SELL$7,927
18 sh
May 20, 2026May 20, 2026
traded May 20, 2026
+0dSEC Form 4

Evidence

2
KA
Kerdman AlinaSVP, Controller & CAO
CTSHCOGNIZANT TECHNOLOGY SOLUTIONS CORP
Open-market sale · 10b5-1 plan
SELL$7,398
154 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

1
RN
Reskos NikolaosChief Operating Officer
SBLKStar Bulk Carriers Corp.
Open-market sale · 10b5-1 plan
SELL$2,278
86 sh
May 19, 2026May 20, 2026
traded May 19, 2026
+1dSEC Form 4

Evidence

1
DS
Dutt SubirChief Sales Officer
XMTRXometry, Inc.
Open-market sale · 10b5-1 plan
SELL$71K
814 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

1
DS
Dutt SubirChief Sales Officer
XMTRXometry, Inc.
Open-market sale · 10b5-1 plan
SELL$225K
2,500 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

1
OC
Ohlgart ChristianeChief Financial Officer
FTNTFortinet, Inc.
Open-market sale · 10b5-1 plan
SELL$31K
238 sh
May 20, 2026May 20, 2026
traded May 20, 2026
+0dSEC Form 4

Evidence

1
DS
Dutt SubirChief Sales Officer
XMTRXometry, Inc.
Open-market sale · 10b5-1 plan
SELL$98K
1,114 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

0
DS
Dutt SubirChief Sales Officer
XMTRXometry, Inc.
Open-market sale · 10b5-1 plan
SELL$21K
237 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

0
DS
Dutt SubirChief Sales Officer
XMTRXometry, Inc.
Open-market sale · 10b5-1 plan
SELL$25K
278 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

43
GN
Gomez Aidan N.Director
RIVNRivian Automotive, Inc. / DE
Open-market purchase
BUY$251K
18.0K sh
May 15, 2026May 19, 2026
traded May 15, 2026
+4dSEC Form 4

Evidence

40
VD
Ventura Salgado DiegoCFO and IR Officer
STNEStoneCo Ltd.
Open-market purchase
BUY$105K
10.9K sh
May 15, 2026May 19, 2026
traded May 15, 2026
+4dSEC Form 4

Evidence